Benzinga's Top Ratings Upgrades, Downgrades For October 7, 2021

Loading...
Loading...

 

Upgrades

  • For State Street Corporation STT, Wolfe Research upgraded the previous rating of Peer Perform to Outperform. In the second quarter, State Street showed an EPS of $1.97, compared to $1.88 from the year-ago quarter. The current stock performance of State Street shows a 52-week-high of $94.64 and a 52-week-low of $57.16. Moreover, at the end of the last trading period, the closing price was at $88.47.
  • According to Wolfe Research, the prior rating for Northern Trust Corp NTRS was changed from Underperform to Peer Perform. In the second quarter, Northern Trust showed an EPS of $1.79, compared to $1.46 from the year-ago quarter. At the moment, the stock has a 52-week-high of $123.10 and a 52-week-low of $76.20. Northern Trust closed at $111.23 at the end of the last trading period.
  • MoffettNathanson upgraded the previous rating for AT&T Inc T from Sell to Neutral. AT&T earned $0.89 in the second quarter, compared to $0.83 in the year-ago quarter. The stock has a 52-week-high of $33.88 and a 52-week-low of $26.35. At the end of the last trading period, AT&T closed at $27.31.
  • According to Goldman Sachs, the prior rating for NIO Inc NIO was changed from Neutral to Buy. In the second quarter, NIO showed an EPS of $0.03, compared to $0.15 from the year-ago quarter. At the moment, the stock has a 52-week-high of $66.99 and a 52-week-low of $20.60. NIO closed at $33.66 at the end of the last trading period.
  • For Marvell Technology Inc MRVL, Craig-Hallum upgraded the previous rating of Hold to Buy. Marvell Technology earned $0.34 in the second quarter, compared to $0.21 in the year-ago quarter. The stock has a 52-week-high of $64.27 and a 52-week-low of $35.30. At the end of the last trading period, Marvell Technology closed at $63.75.
  • For Teradyne Inc TER, DA Davidson upgraded the previous rating of Neutral to Buy. For the second quarter, Teradyne had an EPS of $1.91, compared to year-ago quarter EPS of $1.33. The stock has a 52-week-high of $147.90 and a 52-week-low of $80.57. At the end of the last trading period, Teradyne closed at $109.00.
  • According to Baird, the prior rating for Voyager Therapeutics Inc VYGR was changed from Neutral to Outperform. In the second quarter, Voyager Therapeutics showed an EPS of $0.80, compared to $0.23 from the year-ago quarter. The stock has a 52-week-high of $12.65 and a 52-week-low of $2.46. At the end of the last trading period, Voyager Therapeutics closed at $3.87.
  • For Tata Motors Ltd TTM, Morgan Stanley upgraded the previous rating of Equal-Weight to Overweight. In the first quarter, Tata Motors showed an EPS of $0.16, compared to $0.31 from the year-ago quarter. The stock has a 52-week-high of $24.27 and a 52-week-low of $8.57. At the end of the last trading period, Tata Motors closed at $22.34.
  • According to JP Morgan, the prior rating for Canon Inc CAJ was changed from Neutral to Overweight. For the second quarter, Canon had an EPS of $0.53, compared to year-ago quarter EPS of $0.08. The stock has a 52-week-high of $25.94 and a 52-week-low of $15.46. At the end of the last trading period, Canon closed at $23.70.
  • According to Morgan Stanley, the prior rating for Five Below Inc FIVE was changed from Equal-Weight to Overweight. Five Below earned $1.15 in the second quarter, compared to $0.53 in the year-ago quarter. The current stock performance of Five Below shows a 52-week-high of $237.86 and a 52-week-low of $124.48. Moreover, at the end of the last trading period, the closing price was at $175.75.
  • According to JP Morgan, the prior rating for Schlumberger Ltd SLB was changed from Neutral to Overweight. Schlumberger earned $0.30 in the second quarter, compared to $0.05 in the year-ago quarter. The current stock performance of Schlumberger shows a 52-week-high of $36.87 and a 52-week-low of $13.70. Moreover, at the end of the last trading period, the closing price was at $29.94.
  • For Gogo Inc GOGO, JP Morgan upgraded the previous rating of Underweight to Neutral. In the second quarter, Gogo showed an EPS of $0.12, compared to $1.04 from the year-ago quarter. The stock has a 52-week-high of $19.23 and a 52-week-low of $8.02. At the end of the last trading period, Gogo closed at $14.98.

See all analyst ratings upgrades.

 

Downgrades

  • For Pinnacle West Capital Corp PNW, Guggenheim downgraded the previous rating of Buy to Sell. For the second quarter, Pinnacle West Capital had an EPS of $1.91, compared to year-ago quarter EPS of $1.71. The current stock performance of Pinnacle West Capital shows a 52-week-high of $91.88 and a 52-week-low of $69.89. Moreover, at the end of the last trading period, the closing price was at $74.18.
  • Wolfe Research downgraded the previous rating for Bank of America Corp BAC from Outperform to Peer Perform. In the second quarter, Bank of America showed an EPS of $1.03, compared to $0.37 from the year-ago quarter. The stock has a 52-week-high of $44.75 and a 52-week-low of $23.12. At the end of the last trading period, Bank of America closed at $44.24.
  • For Citrix Systems Inc CTXS, Citigroup downgraded the previous rating of Buy to Neutral. For the second quarter, Citrix Systems had an EPS of $1.24, compared to year-ago quarter EPS of $1.53. The current stock performance of Citrix Systems shows a 52-week-high of $146.94 and a 52-week-low of $94.66. Moreover, at the end of the last trading period, the closing price was at $105.96.
  • For Ally Financial Inc ALLY, Stephens & Co. downgraded the previous rating of Overweight to Equal-Weight. Ally Financial earned $2.33 in the second quarter, compared to $0.61 in the year-ago quarter. The current stock performance of Ally Financial shows a 52-week-high of $56.61 and a 52-week-low of $25.86. Moreover, at the end of the last trading period, the closing price was at $53.69.
  • According to Morgan Stanley, the prior rating for Takeda Pharmaceutical Co Ltd TAK was changed from Overweight to Equal-Weight. For the first quarter, Takeda Pharmaceutical had an EPS of $1.03, compared to year-ago quarter EPS of $1.14. The stock has a 52-week-high of $19.96 and a 52-week-low of $14.11. At the end of the last trading period, Takeda Pharmaceutical closed at $14.31.
  • For Teleflex Inc TFX, Keybanc downgraded the previous rating of Overweight to Sector Weight. For the second quarter, Teleflex had an EPS of $3.35, compared to year-ago quarter EPS of $1.93. At the moment, the stock has a 52-week-high of $449.38 and a 52-week-low of $312.33. Teleflex closed at $378.74 at the end of the last trading period.

See all analyst ratings downgrades.

 

Initiations

  • Morgan Stanley initiated coverage on Imperial Oil Ltd IMO with a Equal-Weight rating. The price target for Imperial Oil is set to $45.00. In the second quarter, Imperial Oil showed an EPS of $0.41, compared to $0.52 from the year-ago quarter. At the moment, the stock has a 52-week-high of $35.20 and a 52-week-low of $11.70. Imperial Oil closed at $32.64 at the end of the last trading period.
  • Morgan Stanley initiated coverage on Cenovus Energy Inc CVE with an Overweight rating. The price target for Cenovus Energy is set to $18.00. Cenovus Energy earned $0.09 in the second quarter, compared to $0.19 in the year-ago quarter. The current stock performance of Cenovus Energy shows a 52-week-high of $10.93 and a 52-week-low of $3.15. Moreover, at the end of the last trading period, the closing price was at $10.57.
  • Morgan Stanley initiated coverage on Suncor Energy Inc SU with an Overweight rating. The price target for Suncor Energy is set to $38.00. Suncor Energy earned $0.39 in the second quarter, compared to $0.71 in the year-ago quarter. The stock has a 52-week-high of $25.73 and a 52-week-low of $10.67. At the end of the last trading period, Suncor Energy closed at $21.56.
  • With a Equal-Weight rating, Morgan Stanley initiated coverage on Canadian Natural Resources Ltd CNQ. The price target seems to have been set at $53.00 for Canadian Natural Res. Canadian Natural Res earned $1.01 in the second quarter, compared to $0.47 in the year-ago quarter. The current stock performance of Canadian Natural Res shows a 52-week-high of $39.30 and a 52-week-low of $15.17. Moreover, at the end of the last trading period, the closing price was at $38.32.
  • With a Buy rating, HC Wainwright & Co. initiated coverage on Lantern Pharma Inc LTRN. The price target seems to have been set at $32.00 for Lantern Pharma. In the second quarter, Lantern Pharma showed an EPS of $0.21, compared to $0.31 from the year-ago quarter. The stock has a 52-week-high of $24.84 and a 52-week-low of $9.00. At the end of the last trading period, Lantern Pharma closed at $9.49.
  • With a Neutral rating, Cantor Fitzgerald initiated coverage on SmartRent Inc SMRT. The price target seems to have been set at $14.00 for SmartRent. Interestingly, in the second quarter, SmartRent's EPS was $4.87. SmartRent closed at $12.57 at the end of the last trading period.
  • B of A Securities initiated coverage on Sylvamo Corp SLVM with a Buy rating. The price target for Sylvamo is set to $38.00. Moreover, at the end of the last trading period, the closing price was at $24.80.
  • With a Buy rating, Berenberg initiated coverage on Life Storage Inc LSI. The price target seems to have been set at $143.00 for Life Storage. For the second quarter, Life Storage had an EPS of $1.22, compared to year-ago quarter EPS of $0.95. The current stock performance of Life Storage shows a 52-week-high of $129.87 and a 52-week-low of $79.78. Moreover, at the end of the last trading period, the closing price was at $117.27.
  • Berenberg initiated coverage on Extra Space Storage Inc EXR with a Buy rating. The price target for Extra Space Storage is set to $198.00. Extra Space Storage earned $1.64 in the second quarter, compared to $1.23 in the year-ago quarter. At the moment, the stock has a 52-week-high of $194.67 and a 52-week-low of $106.33. Extra Space Storage closed at $170.53 at the end of the last trading period.
  • With a Hold rating, Berenberg initiated coverage on CubeSmart CUBE. The price target seems to have been set at $52.00 for CubeSmart. CubeSmart earned $0.50 in the second quarter, compared to $0.41 in the year-ago quarter. At the moment, the stock has a 52-week-high of $55.07 and a 52-week-low of $31.16. CubeSmart closed at $49.06 at the end of the last trading period.
  • With a Hold rating, Berenberg initiated coverage on Public Storage PSA. The price target seems to have been set at $321.00 for Public Storage. In the second quarter, Public Storage showed an EPS of $3.15, compared to $2.46 from the year-ago quarter. The stock has a 52-week-high of $332.95 and a 52-week-low of $212.22. At the end of the last trading period, Public Storage closed at $301.42.
  • Piper Sandler initiated coverage on Vicarious Surgical Inc RBOT with an Overweight rating. The price target for Vicarious Surgical is set to $16.00. At the end of the last trading period, Vicarious Surgical closed at $12.50.
  • Piper Sandler initiated coverage on Organon & Co OGN with a Neutral rating. The price target for Organon is set to $35.00. Organon earned $1.72 in the second quarter. At the moment, the stock has a 52-week-high of $38.24 and a 52-week-low of $27.25. Organon closed at $33.07 at the end of the last trading period.
  • With a Buy rating, Jefferies initiated coverage on Enanta Pharmaceuticals Inc ENTA. The price target seems to have been set at $95.00 for Enanta Pharmaceuticals. Enanta Pharmaceuticals earned $1.19 in the third quarter, compared to $0.71 in the year-ago quarter. The stock has a 52-week-high of $61.49 and a 52-week-low of $40.32. At the end of the last trading period, Enanta Pharmaceuticals closed at $61.20.
  • With a Buy rating, Jefferies initiated coverage on Cytokinetics Inc CYTK. The price target seems to have been set at $75.00 for Cytokinetics. For the second quarter, Cytokinetics had an EPS of $0.86, compared to year-ago quarter EPS of $0.68. At the moment, the stock has a 52-week-high of $37.97 and a 52-week-low of $14.71. Cytokinetics closed at $36.12 at the end of the last trading period.
  • With a Buy rating, Jefferies initiated coverage on Madrigal Pharmaceuticals Inc MDGL. The price target seems to have been set at $151.00 for Madrigal Pharmaceuticals. In the second quarter, Madrigal Pharmaceuticals showed an EPS of $3.72, compared to $3.18 from the year-ago quarter. The stock has a 52-week-high of $142.62 and a 52-week-low of $76.03. At the end of the last trading period, Madrigal Pharmaceuticals closed at $78.35.
  • Jefferies initiated coverage on Global Blood Therapeutics Inc GBT with a Buy rating. The price target for Global Blood Therapeutics is set to $68.00. Global Blood Therapeutics earned $1.12 in the second quarter, compared to $0.86 in the year-ago quarter. At the moment, the stock has a 52-week-high of $64.49 and a 52-week-low of $25.11. Global Blood Therapeutics closed at $25.41 at the end of the last trading period.
  • Jefferies initiated coverage on Exelixis Inc EXEL with a Buy rating. The price target for Exelixis is set to $28.00. For the second quarter, Exelixis had an EPS of $0.37, compared to year-ago quarter EPS of $0.25. The stock has a 52-week-high of $25.77 and a 52-week-low of $16.19. At the end of the last trading period, Exelixis closed at $20.90.
  • Jefferies initiated coverage on argenx SE ARGX with a Buy rating. The price target for argenx is set to $362.00. For the second quarter, argenx had an EPS of $1.98, compared to year-ago quarter EPS of $3.15. At the moment, the stock has a 52-week-high of $382.15 and a 52-week-low of $244.98. argenx closed at $293.30 at the end of the last trading period.
  • With a Hold rating, Jefferies initiated coverage on Acceleron Pharma Inc XLRN. The price target seems to have been set at $180.00 for Acceleron Pharma. For the second quarter, Acceleron Pharma had an EPS of $1.05, compared to year-ago quarter EPS of $0.34. The current stock performance of Acceleron Pharma shows a 52-week-high of $189.99 and a 52-week-low of $99.98. Moreover, at the end of the last trading period, the closing price was at $175.29.
  • Jefferies initiated coverage on BioNTech SE BNTX with a Hold rating. The price target for BioNTech is set to $230.00. For the second quarter, BioNTech had an EPS of $12.97, compared to year-ago quarter EPS of $0.42. The current stock performance of BioNTech shows a 52-week-high of $464.00 and a 52-week-low of $75.34. Moreover, at the end of the last trading period, the closing price was at $236.14.

See all analyst ratings initiations.

Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: UpgradesDowngradesInitiationIntraday UpdateAnalyst RatingsBZI-Ratings
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...